Ajanta Pharma Ltd. (AJANTPHARM) Share Price Hits Fresh 52-Week High at Rs 3,672
- August 13, 2026
- Posted by: Harsh Piplani
- Category: News
Ajanta Pharma Ltd. rose 2.1% to Rs 3,617 after touching a fresh 52-week high of Rs 3,672. The Healthcare stock currently carries a market capitalisation of Rs 43,777.52 crore.
Ajanta Pharma Ltd. Share Price was at Rs 3,617 on 13 August 2026 at 10:17 AM IST, up Rs 74.3 or 2.1% from the previous close of Rs 3,542.7, after the stock touched a fresh 52-week high of Rs 3,672. With a market capitalisation of Rs 43,777.52 crore, the move has put the company firmly on the radar in today’s Stock Market Today and Share Market Today conversation.
The verified data confirms the price event clearly: Ajanta Pharma Ltd. opened at Rs 3,522.75, traded between Rs 3,522.75 and Rs 3,672, and hit a new one-year high during the session. Turnover stood at Rs 1.79 crore with current volume at 4,955 shares, showing actual participation behind the move. The supplied data confirms the stock is trending because it has reached a fresh yearly high, though it does not establish a company-specific catalyst.
For investors tracking Ajanta Pharma Ltd. Stock News, the immediate relevance lies in three things. First, the stock has entered 52 Week High Stocks territory. Second, the company’s valuation and profitability metrics can now be examined against the broader Healthcare benchmark. Third, the market cap places it far above the sector sample median and average provided in the dataset. In this Univest analysis, the focus is on what happened, what the numbers show, and what investors may monitor next.
Ajanta Pharma Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,617 |
| Previous Close | Rs 3,542.7 |
| Today's Change | +Rs 74.3 (+2.1%) |
| Day Open | Rs 3,522.75 |
| Fresh 52-Week High | Rs 3,672 |
| Day Low | Rs 3,522.75 |
| Current Volume | 4,955 |
| Turnover | Rs 1.79 crore |
| Market Capitalisation | Rs 43,777.52 crore |
Ajanta Pharma Ltd. (AJANTPHARM) traded at Rs 3,617. versus the previous close of Rs 3,542.7, a rise of 2.1%. The stock opened at Rs 3,522.75, reached Rs 3,672, touched Rs 3,522.75. Reported volume was 4,955.
Ajanta Pharma Ltd. Share Price Today shows a clear intraday breakout pattern, with the stock opening at Rs 3,522.75, holding that level as the day’s low, and then climbing to Rs 3,672, its fresh 52-week high. The stock remained above the previous close of Rs 3,542.7 and was last seen at Rs 3,617, up 2.1%.
From a pure price-action standpoint, the session reflects strong upward movement within the day’s range. The fact that the day low and opening price were both Rs 3,522.75 suggests that the stock did not slip below its initial trade before advancing. That matters for traders following Price Action and intraday Market Movers because it indicates early support held through the session.
The move from the previous close of Rs 3,542.7 to the intraday high of Rs 3,672 represents a gain of Rs 129.3 at the peak, while the last traded price of Rs 3,617 still leaves the stock well above the prior close. Turnover of Rs 1.79 crore and volume of 4,955 shares show that the one-year high was accompanied by real trades rather than an isolated print. For readers searching Ajanta Pharma Ltd. Share News, this is the central update: the stock reached a fresh 52-week peak and sustained most of the day’s gains.
That makes the next question less about whether the price moved and more about whether the valuation and financial ratios provide context for this fresh high. Univest therefore shifts from price movement to balance-sheet and market-multiple analysis.
Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 43,777.52 crore |
| P/E Ratio | 68.39x |
| P/B Ratio | 10.82x |
| ROE | 18.65% |
| ROCE | 22.17% |
Ajanta Pharma Ltd. was valued at a P/E ratio of 68.39x, a P/B ratio of 10.82x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 18.65% and ROCE of 22.17%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 68.39x |
| Benchmark Median P/E | 21.07x |
| Benchmark Average P/E | 58.79x |
| Benchmark P/E Range | 0x to 3,374.81x |
| Company P/B Ratio | 10.82x |
| Benchmark Median P/B | 1.92x |
| Company ROE | 18.65% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | 22.17% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 43,777.52 crore |
| Benchmark Median Market Cap | Rs 140.78 crore |
Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare.
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 68.39x, which is above the benchmark median of 21.07x, a difference of +224.58%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of 18.65%, which is above the benchmark median of 10.92%, a difference of +70.79%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of 22.17%, which is above the benchmark median of 13.29%, a difference of +66.82%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Beta Drugs Ltd. | BETA | 2,958.04 | 68.39 | 10.82 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,596.51 | 34.07 | 7.02 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,559.74 | 171.25 | 3.13 | 13.9 | 12.97 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,474.06 | 44.25 | 1.76 | -0.78 | 8.31 |
| NGL Fine-Chem Ltd. | NGLFINE | 2,137.26 | 43.8 | 6.4 | 27.9 | 33.91 |
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 68.39x compared with the displayed peer median of 44.25x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.65% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 22.17% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 43,777.52 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Ajanta Pharma Ltd.
The stock is drawing attention because the verified numbers point to a clear event and a meaningful valuation context.
- Ajanta Pharma Ltd. Share Price Today rose 2.1% to Rs 3,617 after touching a fresh 52-week high of Rs 3,672.
- The day’s range of Rs 3,522.75 to Rs 3,672 shows strong intraday upside from the opening level.
- Turnover was Rs 1.79 crore with current volume of 4,955 shares, confirming active trading in today’s session.
- The company’s market capitalisation of Rs 43,777.52 crore stands well above the same-sector median and average.
- P/E of 68.39 and P/B of 10.82 place the stock above the broader Healthcare benchmark on valuation multiples.
- ROE of 18.65% and ROCE of 22.17% are both above the benchmark median and average, supporting investor attention from a profitability perspective.
About Ajanta Pharma Ltd.
Ajanta Pharma Ltd. is a listed Healthcare company tracked on the exchanges under the symbol AJANTPHARM. Based on the supplied market data, it sits within the Healthcare sector and is being compared in the current benchmark set with companies from pharmaceuticals, drugs and broader healthcare services.
In market terms, Ajanta Pharma Ltd. currently stands out for its scale. Its market capitalisation of Rs 43,777.52 crore is far above the benchmark sample average and median in the supplied sector universe, which places it among the larger companies covered by this dataset. That scale is one reason Ajanta Pharma Ltd. Share Price and Ajanta Pharma Ltd. Stock News can attract attention when the stock enters the 52 Week High list.
For readers using Univest for Ajanta Pharma Ltd. Company News, the immediate takeaway is simple: this is a large listed Healthcare name that has moved to a fresh one-year high, and its valuation and return profile make it an important stock to track within the sector.
Track Ajanta Pharma Ltd. Share Price on Univest
Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
On Univest, investors can track Ajanta Pharma Ltd. Share Price Live, daily Share Price updates, 52-week levels, market capitalisation, valuation ratios such as P/E and P/B, profitability indicators including ROE and ROCE, and broader market insights. That makes it easier to follow Ajanta Pharma Ltd. Shareholding Pattern, sector context, stock performance and key developments in one place.
For users checking Ajanta Pharma Ltd. News Today or Ajanta Pharma Ltd. Share Price Today, Univest helps connect the latest price move with the company’s fundamental ratios and peer positioning. After a fresh 52-week high, that wider context matters as much as the headline price itself.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Ajanta Pharma Ltd. Share Price Today?
Ans. Ajanta Pharma Ltd. Share Price Today was Rs 3,617 at 10:17 AM IST on 13 August 2026. The stock was up Rs 74.3, or 2.1%, from its previous close of Rs 3,542.7.
Did Ajanta Pharma Ltd. hit a fresh 52-week high today?
Ans. Yes, the stock touched a fresh 52-week high of Rs 3,672 during the session. It later traded at Rs 3,617, still above the previous close, keeping Ajanta Pharma Ltd. among closely watched 52 Week High Stocks.
Why is Ajanta Pharma Ltd. rising today?
Ans. The supplied data confirms that Ajanta Pharma Ltd. rose 2.1% and hit a new one-year high in today’s trade. It verifies the price event and trading activity, though it does not identify a company-specific catalyst.
What was Ajanta Pharma Ltd.'s opening, high and low today?
Ans. Ajanta Pharma Ltd. opened at Rs 3,522.75, which also remained the day’s low, and then climbed to an intraday high of Rs 3,672. That range highlights strong upward price action through the session.
What is the market capitalisation of Ajanta Pharma Ltd.?
Ans. Ajanta Pharma Ltd. has a market capitalisation of Rs 43,777.52 crore. In the supplied Healthcare benchmark, that is far above the median market cap of Rs 140.78 crore and average market cap of Rs 466.2 crore.
How is Ajanta Pharma Ltd. valued on P/E and P/B?
Ans. The stock trades at a P/E ratio of 68.39 and a P/B ratio of 10.82. Both are above the same-sector median of 21.07 and 1.92, and also above the sector averages provided.
How profitable is Ajanta Pharma Ltd. based on ROE and ROCE?
Ans. Ajanta Pharma Ltd. reports ROE of 18.65% and ROCE of 22.17%. Both figures are above the Healthcare sector benchmark median and average in the supplied dataset, indicating stronger-than-typical return ratios within that universe.
How does Ajanta Pharma Ltd. compare with Healthcare peers?
Ans. Ajanta Pharma Ltd. is much larger than the supplied peers by market cap at Rs 43,777.52 crore. Its valuation is premium versus several peers, while its ROE and ROCE are stronger than many, though not all, comparables.
What was the turnover and volume in Ajanta Pharma Ltd. today?
Ans. The stock recorded turnover of Rs 1.79 crore with current volume of 4,955 shares. Those figures show that the fresh 52-week high was accompanied by actual market participation during the trading session.
What should investors monitor after this Ajanta Pharma Ltd. 52-week high?
Ans. Investors may watch whether Ajanta Pharma Ltd. holds above recent breakout levels, how its premium valuation compares with sector benchmarks, and whether future company financials continue to support ROE of 18.65% and ROCE of 22.17%.
